References
- The Pharmaceutical Pricing Regulation Scheme: A Market Study. UK Office of Fair Trading, London, UK (2007).
- Claxton K. OFT, VPB QED? Health Econ.16, 545–558 (2007).
- Towse A. If it ain’t broke don’t fix it: the OFT and the PPRS. Health Econ.15, 653–667 (2007).
- Ess S, Schneeweiss S, Szucz, T. European health care policies for controlling drug expenditure. Pharmacoeconomics21, 89–103 (2003).
- Gerber A, Stock S, Chardabos-Markos D. Reflections on the changing face of German pharmaceutical policy: how far is Germany from value based pricing? Pharmacoeconomics29, 673–685 (2011).
- Bryan S, Sofaer S, Siegelberg T, Gold M. Has the time come for cost–effectiveness analysis in U.S. health care? Health Econ. Policy Law4, 425–443 (2009).